Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24571755 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children
Condition: The Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and Infants
Interventions: Biological: 100U/0.5ml in 6-11 months old infants;   Biological: 100U/0.5ml in 12-23 months old infants;   Biological: 100U/0.5ml in 24-35 months old children;   Biological: 100U/0.5ml in 36-71 months old children

Indicates status has not been verified in more than two years